Aurinia Pharmaceuticals Inc.·4

May 23, 5:16 PM ET

MILNE GEORGE M JR 4

4 · Aurinia Pharmaceuticals Inc. · Filed May 23, 2023

Insider Transaction Report

Form 4
Period: 2023-05-18
Transactions
  • Exercise/Conversion

    Common Stock

    2023-05-18+8,73378,733 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-05-188,7330 total
    From: 2023-05-18Common Stock (8,733 underlying)
Footnotes (1)
  • [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.

Documents

1 file
  • 4
    wk-form4_1684876599.xmlPrimary

    FORM 4